Systemic inflammation mediated 17% of the association between psoriasis severity and subclinical atherosclerosis. It also mediated 37% of the link between psoriasis severity and cardiovascular events.
Tumor heterogeneity remains a formidable obstacle in targeted cancer therapy, often leading to suboptimal treatment outcomes. This study presents an innovative approach that harnesses controlled ...